These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The atypical chemokine receptor-2 does not alter corneal graft survival but regulates early stage of corneal graft-induced lymphangiogenesis. Yu T; Forrester JV; Graham GJ; Kuffova L Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1875-1882. PubMed ID: 30054731 [TBL] [Abstract][Full Text] [Related]
5. Use of anterior segment optical coherence tomography to predict corneal graft rejection in small animal models. Liu YC; Lwin NC; Chan NS; Mehta JS Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6736-41. PubMed ID: 25249608 [TBL] [Abstract][Full Text] [Related]
6. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Hori J; Streilein JW Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):720-6. PubMed ID: 11222533 [TBL] [Abstract][Full Text] [Related]
7. Analysis of macrophage phenotype in rejected corneal allografts. Oh JY; Lee HJ; Ko AY; Ko JH; Kim MK; Wee WR Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7779-84. PubMed ID: 24159090 [TBL] [Abstract][Full Text] [Related]
8. Early expression of proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha after corneal transplantation. Zhu S; Dekaris I; Duncker G; Dana MR J Interferon Cytokine Res; 1999 Jun; 19(6):661-9. PubMed ID: 10433368 [TBL] [Abstract][Full Text] [Related]
9. Survival in high-risk eyes of epithelium-deprived orthotopic corneal allografts reconstituted in vitro with syngeneic epithelium. Hori J; Streilein JW Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):658-64. PubMed ID: 12556396 [TBL] [Abstract][Full Text] [Related]
10. Effect of alloantibodies on corneal allograft survival. Hegde S; Mellon JK; Hargrave SL; Niederkorn JY Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241 [TBL] [Abstract][Full Text] [Related]
11. CD95 ligand expression on corneal epithelium and endothelium influences the fates of orthotopic and heterotopic corneal allografts in mice. Osawa H; Maruyama K; Streilein JW Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1908-15. PubMed ID: 15161857 [TBL] [Abstract][Full Text] [Related]
12. Preliminary findings in corneal allograft rejection in patients with keratoconus. Hargrave S; Chu Y; Mendelblatt D; Mayhew E; Niederkorn J Am J Ophthalmol; 2003 Apr; 135(4):452-60. PubMed ID: 12654360 [TBL] [Abstract][Full Text] [Related]
13. Establishment of a murine model of chronic corneal allograft dysfunction. Gao H; Shi W; Gong H; Wang Y; Wang Y; Xie L Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1437-45. PubMed ID: 20473766 [TBL] [Abstract][Full Text] [Related]
14. Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice. Asai T; Choi BK; Kwon PM; Kim WY; Kim JD; Vinay DS; Gebhardt BM; Kwon BS Immunology; 2007 Jul; 121(3):349-58. PubMed ID: 17376197 [TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-2 Blockade Promotes Survival of Corneal Transplants. Zhang L; Li G; Sessa R; Kang GJ; Shi M; Ge S; Gong AJ; Wen Y; Chintharlapalli S; Chen L Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):79-86. PubMed ID: 28061513 [TBL] [Abstract][Full Text] [Related]
16. Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice. Hori J; Streilein JW Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1820-8. PubMed ID: 11431448 [TBL] [Abstract][Full Text] [Related]
17. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Sano Y; Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710 [TBL] [Abstract][Full Text] [Related]
18. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants. Qian Y; Boisgerault F; Benichou G; Dana MR Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076 [TBL] [Abstract][Full Text] [Related]
19. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber. Yamada J; Streilein JW Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules. Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]